, by inhibiting duplex unwinding (5) , or by inducing mutations in the targeted gene (6, 7) . This non-vector-based approach to manipulating gene expression does not appear to be cell type restricted, but it is constrained by the need for polypurine/polypyrimidine target sequences. Nonetheless, genetic manipulation has been achieved via triple helix formation in the nuclei of intact cells (6, 7) . A larger body of work has focused on the anti-mRNA or so-called "antisense" strategies, composed principally of the use of ribozymes and antisense oligodeoxynucleotides (AS ODNs). Anti (8, 13) . A particularly important example of the utility of this approach was the AS ODNgenerated suggestion that the c-mpl receptor would bind a ligand with specific effects on megakaryocyte development (14) . This observation led directly to the cloning of thrombopoietin, the longsought hematopoietic hormone, which is the predominant regulator of megakaryocytopoiesis and platelet development (15 (19, 20 (22) .
To resolve the problems of uptake and trafficking, a large number of very clever strategies have been tried in order to augment the rate of cellular internalization of nucleic acids and to increase the rate at which they pass through the endosomal membrane. These strategies have met with variable levels of success and include, but are not limited to (i) coupling of oligomers to polycations such as polylysine (23), polyethylenime (24) , or other "interpolyelectrolyte complexes" (25) , (ii) use of transferrin/polylysine-conjugated DNA in the presence of the capsid of a replication-deficient adenovirus (26) , (iii) conjugation of oligonucleotides to fusogenic peptides (27) or to a peptide fragment of the homeodomain of the Drosophila antennapedia protein (28), (iv) targeting of oligonucleotides to specific cell surface receptors, such as the folate (29) , asialoglycoprotein receptors (30) , and transferrin (31), (v) conjugation to cholesterol (32) , and, most successfully (vi) complexation of oligonucleotides with cationic lipids (33) . However, many of these lipids, which are in common laboratory use, suffer from problems of applicability ranging from lack of serum stability to cellular toxicity.
The work by Lewis et (8, 13) will certainly address this issue.
The antisense approach has generated controversy with regard to mechanism of action, reliability, and ultimate therapeutic utility. Nevertheless, the potential power of this method remains undisputed.
For this reason, we believe that efforts should be increased to decipher the mechanism of action of antisense ODN and to learn how they may be successfully used in the clinic. To the extent that GS2888 may facilitate these goals, we applaud the work of Lewis and colleagues. The community anxiously awaits the widespread availability of this reagent for further testing.
